Tobramycin Solution
Product Images NDC 67877-678

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 67877-678). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-a.jpg (Figure A)

An instructional diagram illustrating components of a respiratory inhalation setup for Tobramycin solution. Labeled parts include an air compressor, nebulizer cup, inspiratory valve cap, ampule, tubing, mouthpiece, and clean paper or cloth towels, arranged on a flat surface.*

FDA Label Image

Figure-b.jpg (Figure B)

An instructional illustration showing two hands holding and inverting small respiratory solution containers to prepare Tobramycin inhalation solution for use. The image emphasizes proper handling before administration.*

FDA Label Image

Figure-c.jpg (Figure C)

An illustration showing a vial with a label spot for lot number and a marked area indicating the location of the expiration date on the vial. The vial has a cap, and an arrow points to the label area where the expiration date is printed.*

FDA Label Image

Figure-d.jpg (Figure D)

An instructional diagram illustrating the assembly of a respiratory nebulizer device for inhalation solution administration. It labels key components including the Mouthpiece, Nebulizer Cup, Nebulizer Top, Inspiratory Valve Cap, and Tubing, showing how the parts fit together for use.*

FDA Label Image

Figure-e.jpg (Figure E)

An instructional diagram showing how to insert the nebulizer insert into the nebulizer cup. The image includes hands holding the parts with labels pointing to the top, nebulizer insert, and nebulizer cup, illustrating the correct assembly for respiratory inhalation use.*

FDA Label Image

Figure-f.jpg (Figure F)

An instructional diagram showing a nebulizer cup and its top part placed on clean paper or cloth towels. The image highlights the components of a nebulizer used for respiratory inhalation therapy, with labels indicating the nebulizer cup, its top, and the clean surface beneath them.*

FDA Label Image

Figure-g.jpg (Figure G)

An instructional illustration showing a hand placing an item into a Pulmo-Aide device, used for respiratory inhalation therapy. The diagram focuses on the proper placement of medication or components within the device.*

FDA Label Image

Figure-h.jpg (Figure H)

An instructional line drawing showing a hand unplugging an electrical cord from a wall outlet. The illustration emphasizes the action of pulling the plug straight out from the socket.*

FDA Label Image

Figure-i.jpg (Figure I)

An instructional line drawing showing how to remove the cap from a Tobramycin inhalation solution vial. The image highlights the "Bottom Tab" on the vial as part of the opening process, demonstrating a hand pulling the cap downward to open the vial used for respiratory inhalation.*

FDA Label Image

Figure-j.jpg (Figure J)

An instructional illustration showing a hand squeezing a drop from a small bottle, presumably Tobramycin solution, into a respiratory inhalation device. The image demonstrates the proper way to add the medication to the inhaler before use.*

FDA Label Image

Figure-k.jpg (Figure K)

An instructional diagram showing assembly of a respiratory nebulizer device with labeled parts: nebulizer top, stem, nebulizer outlet, and nebulizer cup. The diagram also includes an arrow indicating how to attach the nebulizer top by rotating it onto the nebulizer cup.*

FDA Label Image

Figure-l.jpg (Figure L)

An instructional illustration showing assembly of a nebulizer for respiratory inhalation. It depicts the connection of a mouthpiece to the nebulizer outlet on top of a nebulizer cup, with directional arrows indicating how to attach the parts.*

FDA Label Image

Figure-m.jpg (Figure M)

An instructional diagram showing the assembly of a respiratory inhalation device, specifically depicting the placement of the inspiratory valve cap onto the device's main body. The diagram features arrows indicating how the valve cap is attached from above.*

FDA Label Image

Figure-n.jpg (Figure N)

An instructional diagram showing a respiratory inhalation device with an air intake labeled on its main chamber. Two arrows point upward indicating connection to a smaller attachment piece below, which appears to connect to tubing. The image illustrates assembly or use of the inhalation apparatus.*

FDA Label Image

Figure-o.jpg (Figure O)

An instructional illustration showing a hand pressing a button or latch on a device labeled "Pulmo-Aide." The image likely demonstrates operation or assembly of a respiratory inhalation device related to Tobramycin solution use.*

FDA Label Image

Figure-p.jpg (Figure P)

An instructional illustration showing a nebulizer device emitting aerosol mist, used for respiratory inhalation of medication such as Tobramycin solution. The diagram highlights the device mouthpiece and airflow direction during inhalation therapy.*

FDA Label Image

Figure-q.jpg (Figure Q)

An instructional illustration showing the use of a respiratory inhalation device with a nose clip. The image depicts a side profile of a person using the inhalation solution with the nose clip in place, indicating proper administration technique for Tobramycin respiratory solution.*

FDA Label Image

Tob01 (Tob01)

Chemical structure of tobramycin, showing the molecular arrangement of its sugar rings and amino groups as a compound used in the pharmaceutical product Tobramycin 300 mg/5mL respiratory solution.*

FDA Label Image

Tob02 (Tob02)

A line graph titled 'Relative Change From Baseline in FEV1 % Predicted' shows average relative change in FEV1 percentage predicted over 24 weeks. It compares Tobramycin Inhalation Solution (studies 1 and 2) and placebo groups, with Tobramycin groups showing higher relative improvement in FEV1 compared to placebo. Data points are plotted by week with annotations for drug administration periods.*

FDA Label Image

Tob03 (Tob03)

A line graph titled 'Absolute Change From Baseline in Log10 CFUs' showing average change of Log10 CFUs on the y-axis and weeks 0 to 24 on the x-axis. It compares Study 1 and Study 2 results for Tobramycin Inhalation Solution versus Placebo, with 'on drug' treatment periods marked at weeks 0-4, 8-12, and 16-20.*

FDA Label Image

Tob04-1.jpg (Tob04 1)

Label for Tobramycin Inhalation Solution, USP 300 mg/5 mL Ampules by Ascend Laboratories, LLC. The label states use by nebulizer only, no preservatives, storage instructions (refrigerate at 2 to 8°C), and package contents of 7 x 5 mL single-dose ampules. Manufacturer is Holopack Verpackungstechnik GmbH, Germany, distributed by Ascend Laboratories, Parsippany, NJ. Includes barcode and QR code with GTIN information.*

FDA Label Image

Tob05-1.jpg (Tob05 1)

Label for Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules by Ascend Laboratories, LLC. The carton contains 56 single-dose 5 mL ampules in 7 pouches with 8 pouches per carton. The label instructs to store the product in a refrigerator and indicates Rx only. The manufacturer is Holopack Verpackungstechnik GmbH, Germany, and the distributor is Ascend Laboratories, LLC, Parsippany, NJ.*

FDA Label Image

Tob06-1.jpg (Tob06 1)

Label for Tobramycin Inhalation Solution, USP 300 mg/5 mL Ampule. Distributed by Ascend Laboratories, LLC. Intended for inhalation use only by nebulizer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.